p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins

Published:2011-07 Issue:10 Volume:47 Page:1585-1594
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Yu Huimei,Su Jing,Xu Ye,Kang Jinsong,Li Hongyan,Zhang Ling,Yi Haowei,Xiang Xiyan,Liu Fei,Sun Liankun

Funder

National Natural Science Foundation of China

‘211 project’ of Jilin University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. Global cancer statistics, 2002;Parin;CA Cancer J Clin,2005

2. Ovarian cancer: strategies for overcoming resistance to chemotherapy;Agarwal;Nat Rev Cancer,2003

3. Recurrent ovarian cancer;Tummala;Clin Adv Hematol Oncol,2005

4. BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma;Beale;Br J Cancer,2000

5. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function;Fraser;Int J Cancer,2008

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ABT‑737 increases cisplatin sensitivity through the ROS‑ASK1‑JNK MAPK signaling axis in human ovarian cancer cisplatin‑resistant A2780/DDP cells;Oncology Reports;2024-07-23

2. Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy;Cancer Biology & Medicine;2023-10-10

3. Mechanisms of autophagy and endoplasmic reticulum stress in the reversal of platinum resistance of epithelial ovarian cancer cells by naringin;Molecular Biology Reports;2023-06-16

4. Nanoparticle-Based Combination Therapy for Ovarian Cancer;International Journal of Nanomedicine;2023-04

5. The Role for AVE0991 (MAS-Receptor Angiotensin II (1-7) Agonist) in Reducing Cisplatin-Induced Acute Kidney Injury on C57BL/6 Mice;Journal of Biosciences and Medicines;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3